Sepsis-Induced Cardiomyopathy: Mechanisms and Treatments

Yan-Cun Liu1, Mu-Ming Yu1, Song-Tao Shou1

  • 1Department of Emergency Medicine, Tianjin Medical University General Hospital, Tianjin, China.

Frontiers in Immunology
|October 4, 2017
PubMed

Insights

Sepsis-induced cardiomyopathy (SIC) is a reversible heart dysfunction contributing to sepsis severity. Understanding SIC

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Pathophysiology

Background:

  • Sepsis is a life-threatening condition with significant economic impact.
  • Sepsis-induced cardiomyopathy (SIC) is a key factor in sepsis pathogenesis, affecting heart function globally.
  • SIC involves complex mechanisms including inflammation, immune dysfunction, and coagulation disorders.

Purpose of the Study:

  • To review recent literature on the mechanisms of sepsis-induced cardiomyopathy (SIC).
  • To explore current and emerging treatments for SIC.
  • To provide insights for researchers and guide new therapeutic strategies for sepsis.

Main Methods:

  • Literature review of recent studies on SIC.
  • Analysis of the complex pathogenesis of SIC.
  • Examination of various treatment modalities for SIC.

Main Results:

  • SIC pathogenesis involves inflammatory mediators, mitochondrial dysfunction, oxidative stress, calcium dysregulation, autonomic nervous system imbalance, and endothelial dysfunction.
  • Treatment approaches for SIC include signal pathway intervention, traditional Chinese medicine, and other specific therapies.
  • The review synthesizes current knowledge on SIC mechanisms and treatments.

Conclusions:

  • Sepsis-induced cardiomyopathy is a critical, yet reversible, cardiac complication of sepsis.
  • A comprehensive understanding of SIC's multifaceted pathogenesis is crucial for effective treatment.
  • Further research into SIC mechanisms and therapies holds promise for improving sepsis patient outcomes.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
506
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
242
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
634
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
550
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
662
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
628